The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center
R

Prevention and Treatment of Disease Relapse After Allogeneic HCT

By The University of Kansas Cancer Center FEATURING Robert Soiffer
By The University of Kansas Cancer Center FEATURING Robert Soiffer
1 view
June 2, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
40:05

Mitigating Toxicities Associated With CAR T-Cell Therapies

The University of Kansas Cancer Center

S. Kenderian

14 views
30:52

Treatment of Aggressive B-Cell Lymphoma: SCT vs. CAR-T

The University of Kansas Cancer Center

M. Hamadani

59 views
30:18

Survivorship and Late Effects After Stem Cell Transplantation and CA…

The University of Kansas Cancer Center

N. Ahmed

33 views
41:31

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate…

The University of Kansas Cancer Center

J. McGuirk

28 views
43:41

Prevention and Treatment of Disease Relapse After Allogeneic HCT

The University of Kansas Cancer Center

R. Soiffer

30:51

Preventing Post-Transplant Relapse With Targeted Therapies

The University of Kansas Cancer Center

M. Levis